Patent US5262423A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5262423A Expired / Lapsed US ⏱️ 0.0 years remaining

Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents

Assignee: Wyeth LLC
•
Filing: 1992-10-29
•
Granted: 1993-11-16
•
Expires: 2012-10-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract N-arylcarbonyl and N-alkylcarbonyl carbamates of rapamycin of the formula shown below wherein ##STR1## R 1 and R 2 are both ##STR2## and where A is lower alkoxy or aryl or heteroaryl, R 3 is H or methyl and R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl or C 2 -C 6 alkynyl possess immunosuppressive and/or antifungal and/or antitumor and/or antiinflammatory activity in vitro and/or inhibit thymocyte proliferation in vivo. These compounds are thus expected to be useful in the treatment of transplantation rejection, autoimmune diseases, fungal infections, cancer, and diseases of inflammation.

Inventors

  • 👤 Wenling Kao

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 05:40
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18; A; A61; A61P; A61P29/00; A61P31/00; A61P31/10; A61P37/00; A61P37/02; A61P37/06

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 150 words
A compound according to the formula: ##STR12## wherein R 1 is ##STR13## and R 2 is H or ##STR14## R 1 and R 2 are both ##STR15## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl or 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzo[b]thiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 150 words
A compound according to the formula: ##STR12## wherein R 1 is ##STR13## and R 2 is H or ##STR14## R 1 and R 2 are both ##STR15## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl or 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzo[b]thiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 12 words
A compound according to claim 1 wherein A is phenyl or methoxy.
Claim 4
Dependent Claim 13 words
A compound according to claim 1 which is rapamycin 42-ester with benzoylcarbamic acid.
Claim 5
Dependent Claim 16 words
A compound according to claim 1 which is rapamycin 31-ester with N,N-dimethylglycine, 42-ester with benzoylcarbamic acid.
Claim 6
Dependent Claim 12 words
A compound according to claim 1 which is rapamycin-31,42-diester with benzoylcarbamic acid.
Claim 7
Dependent Claim 13 words
A compound according to claim 1 which is rapamycin 42-ester with N-methoxycarbonylcarbamic acid.
Claim 8
Independent Claim 173 words
A method of treating transplantation rejection, host vs. graft disease, and diseases of inflammation in a mammal by administering thereto an effective amount of a compound having the formula: ##STR16## wherein R 1 is ##STR17## and R 2 is H or ##STR18## R 1 and R 2 are both ##STR19## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 9
Independent Claim 173 words
A method of treating transplantation rejection, host vs. graft disease, and diseases of inflammation in a mammal by administering thereto an effective amount of a compound having the formula: ##STR16## wherein R 1 is ##STR17## and R 2 is H or ##STR18## R 1 and R 2 are both ##STR19## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim 14 words
A method of treatment according to claim 7 wherein A is phenyl or methoxy.
Claim 11
Dependent Claim 161 words
A pharmaceutical composition comprising a pharmaceutical carrier and an effective amount of a compound of the formula: ##STR20## wherein R 1 is ##STR21## and R 2 is H or ##STR22## R 1 and R 2 are both ##STR23## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim 161 words
A pharmaceutical composition comprising a pharmaceutical carrier and an effective amount of a compound of the formula: ##STR20## wherein R 1 is ##STR21## and R 2 is H or ##STR22## R 1 and R 2 are both ##STR23## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-11-15 1997-05-17 1997-11-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-11-15 2001-05-17 2001-11-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-11-15 2005-05-17 2005-11-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag